Koyfin Home > Directory > Health Care > Adamas Pharma > Total Equity

Adamas Pharma Total Equity Chart (ADMS)

Adamas Pharma annual/quarterly Total Equity from 2012 to 2020.
  • Adamas Pharma Total Equity for the quarter ending June 06, 2020 was $-24m a 180.94% decrease of -44m year over year
  • Adamas Pharma Total Equity for the last 12 months ending June 06, 2020 was $-24m a 180.94% decrease of -44m year over year
  • Adamas Pharma Annual Total Equity for 2019 was $-1m a 10,165.51% decrease of -91m from 2018
  • Adamas Pharma Annual Total Equity for 2018 was $90m a 26.43% increase of 24m from 2017
  • Adamas Pharma Annual Total Equity for 2017 was $66m a -99.90% decrease of -66m from 2016
Other Balance Sheet Metrics:
  • Adamas Pharma Total Assets for the quarter ending September 09, 2018 was $257m a 27.59% increase of 71m year over year
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
View Chart On Koyfin

Quarterly ADMS Total Equity Data

06/2020$-24m
03/2020$-16m
12/2019$-1m
09/2019$20m
06/2019$43m
03/2019$64m
12/2018$90m
09/2018$114m
06/2018$143m
03/2018$170m

Annual ADMS Total Equity Data

2019$-1m
2018$90m
2017$66m
2016$132m
2015$116m
2014$147m
2013$82m
2012$26m
2011$2m